CD47 and acute myeloid leukemia: Majeti et al. (38) and Yang et al. (39) demonstrated that CD47 mRNA and protein levels in leukemia stem cells from AML patients were higher than those in normal healthy stem cells and that these increases were associated with poor prognosis.